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Summary 
We have generated several transgenic mouse strains carrying a human immunodeficiency virus 
1 (HIV-1)  NEF/3'  long  terminal repeat (LTR)  transgene under control of a T  cell-specific 
promoter-enhancer element, showing a depletion of CD4 + T cells in the thymus and periphery. 
The immunological functions of the line with the most dramatic changes in lymphocyte populations, 
B6/338L,  were analyzed in greater detail.  The presence of the transgene in the heterozygous 
animal is associated  with a dominant severe immunodeficiency. Older animals develop lymph- 
adenopathy and splenomegaly. CD4 § CD8 § and CD4 § CD8-  single positive thymocytes already 
are depleted in these mice at the earliest stages in ontogeny, and peripheral T  cells are reduced 
in frequency and present cell surface marker expression, which is characteristic for memory and 
activated T  cells.  The immunological response of B6/338L  mice to several viral infections is 
also greatly impaired. Thus, the HIV-1 NEF/3' LTR as transgene in T cells can cause immuno- 
deficiency and disease with striking similarities  to a known retrovirus-induced immunodeficiency 
called murine AIDS (H.  C. Morse III, S. K. Chattopadhyay, M. Makino, T. N. Frederickson, 
A.  W.  H/igin,  and J.  W.  Hartley.  1992.  AIDS.  6:607). 
I 
nfection of C57BL/6 mice with a mixture of viruses re- 
covered from the Duplan Laterjet strain of MuLVs induces 
in certain strains of mice a severe immunodeficiency disease 
called murine AIDS  (MAIDS) 1 which has  similarities  to 
AIDS in humans (1). The virus responsible for the profound 
immunodeficiency is a defective MuLV termed BMSd (2) or 
Du5H (3). The disease is characterized by pronounced spleno- 
megaly and lymphadenopathy, by polyclonal activation and 
proliferation of T  and B cells (1, 4) and markedly impaired 
responses to mitogenic and specific antigenic stimuli (5), as 
well as enhanced susceptibility to infection (6) and late stage 
lymphomas. The pathogenesis is still unclear as is that caused 
by HIV-1. 
The nefgene is found in all primate lentiviruses, HIV-1, 
HIV-2, and simian immunodeficiency viruses (SIV), but is 
highly polymorphic. However, in contrast to other viral regula- 
tory genes, tat and rev, nef is dispensable for virus growth 
in vitro (7)  and remains without a precisely defined func- 
tion. The Nef protein is encoded by a single open reading 
1 Abbreviations used in this paper: LCMV, lymphocyte  choriomeningitis 
virus; MAIDS, murine AIDS; ntg, nontransgenic;  ORF, open reading 
frame; SIV, simian  immunodeficiency  virus; tg, transgenic;  VSV, vasicular 
stomatitis virus. 
frame (ORF) located at the 3' end of the HIV-1 genome, 
partially overlapping the 3' LTR. It is found as a 27-kD pro- 
tein NH2-terminally myristoylated and associated  with cy- 
toplasmic membrane structures (8).  Nevertheless, free non- 
myristoylated, 25-kD forms initiated at an internal AUG codon 
(9) also have been detected in the cytoplasm of infected cells. 
Early mutational experiments demonstrated a participation 
of Nef in downregulation of HIV-1 expression (10), hence 
its name "negative factor". However, other reports using iden- 
tical nef genes or gene products were unable to detect any 
negative effect on HIV-1 replication (11). Moreover, recent 
experiments show that natural nef alleles accelerate HIV-1 
replication in primary T-lymphocytes (12), and that the nat- 
ural HIV-1,  ELI nef allele promotes efficient HIV-1 infec- 
tion in primary mononuclear cells  (13). 
It has been demonstrated that Nef can influence the ex- 
pression of two cellular proteins, CD4 and IL-2 (14-16). Two 
different mechanisms of downregulation by Nef seem to be 
involved. IL-2 production in response to antigen receptor- 
mediated stimulation is inhibited at the transcriptional level 
(16), whereas cell surface expression of CD4 in Nef-expressing 
cells is downregulated by a posttranscriptional mechanism 
(15). The relevance of these effects in the pathogenesis of AIDS 
is not yet clear. 
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tivity of Nef in vivo, Kestler et al.  (17) have studied SIVM^c 
infection of rhesus monkeys with infectious molecular clones 
bearing different nefgenes. Their results suggest that the SIV 
nefgene is necessary for efficient replication and full patho- 
genesis in infected rhesus monkeys, which implies for Nef 
a  function as a  positive factor in vivo. 
In this paper, we describe transgenic (tg) animals as a model 
system to examine Nef function in vivo. To study the influence 
of Nef expression on T cell maturation and function, tg mice 
were generated carrying the HIV-1 nefgene under control 
of a T  cell-specific regulatory element. In different indepen- 
dent tg lines, phenotypic changes in lymphocyte populations 
of thymus and peripheral lymphoid organs were observed at 
various degrees, mainly affecting the CD4 + T  cell lineage. 
Materials and Methods 
Mice.  C57BL/6,  (C57BL/6  x  DBA/2)F,  and pseudopreg- 
nant Moro mice were purchased from Biological Research Labora- 
tories,  Ltd.  (Fuellinsdorf,  Switzerland).  C57BL/6-PbThyla/Cy 
were obtained from The Jackson Laboratory (Bar Harbor, ME). 
Generation ofTCg-NEF Tg Mice.  The mouse TCR ~ chain en- 
hancer-promotor dement (18) was constructed by fusing a 5.5-kb 
BamHI/KpnI fragment containing the mTCR ~/chain core en- 
hancer elements (19) to a 1.8-kb BamHI/KpnI fragment containing 
the mV~8.3 TCR B chain promotor. This regulatory control ele- 
ment was fused to a PCR fragment comprising nucleotides (nt) 
7956-9484 of the HIV-1,  Bru genome (20) containing the com- 
plete nefORF. The construct was injected as a 9-kb SmaI frag- 
ment into (C57BL/6 x  DBA/2)  x  (C57BL/6  x  DBA/2)zygotes 
according to protocols described by Bluethmann and Steinmetz (21). 
Tg founder mice were mated to C57BL/6J mice to establish per- 
manent inbred Tg lines. The transgene transmission was followed 
by Southern blot analysis and PCR analysis. 
PCR Analysis.  Amplifications of mouse tail DNA (22) were 
performed using the GeneAmp kit (Perkin-Elmer AG, Kuesnacht, 
Switzerland) according to the manufacturer's instructions. Trans- 
gene-specific  primers  used  were  N29  (5'-ATGGGTGGCAAG- 
TGGTCAAAAAGT-3')  5' primer and N30 (5'-TCAGCAGTTCTT- 
GAAGTACTCCGG-3') 3' primer. Amplifications were done in 35 
cycles of 30 s at 95~  45 s at 69~  and 1 min at 72~  Tg offspring 
showed a 621-bp  transgene-specific  band upon agarose  gel elec- 
trophoresis. 
RNA PCR.  For RNA isolation,  tissues  were removed and 
quickly frozen in liquid nitrogen and stored at  -80~  until ana- 
lyzed. RNA was extracted by a modified single-step  method (23). 
1-5/~g total RNA was used as a template with oligo p(dT)12-18 
as primer and Moloney-murine leukemia virus (M-MLV) H- RT 
(GIBCO BRL, Gaithersburg, MD) in a cDNA synthesis reaction 
at 42~  according to the manufacturer's instructions. After addi- 
tional RNase H (Pharmacia, Diibendorf, Switzerland) treatment 
at 37~  cDNA was used in a PCR amplification. Transgene-specific 
primer sets used were oligonucleotides N205 (5'-CCTGCAGAC- 
CCACCTCCCAACC-3')  5' primer/N507  (5'-GCGCGCCGC- 
TTTTTTTTTTTTTTTTTTTTTTTTTTTTTGAAGCAC-3') 
3' primer, and N201 (5'-CGAGGGGACCCGACAGGCCCG-Y) 
5' primer/N507 3' primer, yielding products of '~1.3 and ,-1.2 
kb in length for amplifications  1 and 2, respectively.  Amplificat- 
ions were done for 30-40 cycles using cycles of 30 s at 95~  1 
rain at 66~  and 1.5 min at 72~  For control amplifications, 
TCR C/32 chain mRNA (24)-specific primers oligonucleotide sets 
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N210  (5'-ACCCTCAGGCCTACAAGGAGAGC-Y)/N207  (5'- 
GCAGGAAAATCTATGGCCAGGGTG-Y) and  N211  (5'-CTA- 
CTGCCTGAGCAGCCGCCTG-3')/N 209  (5'-GGTGAAGAA- 
CGGCTCAGGATGCATA-Y) were used, yielding products of 410 
and 360 bp in length for amplifications  1 and 2, respectively. 
Antibodies Used in Flow Cytometry Analysis.  The following an- 
tibodies against different antigens were used. CD4 (GK1.5, Becton 
Dickinson & Co., Mountain View, CA; and RM-4-5, Pharmingen, 
San Diego, CA), CD8 (53-6.7, Becton Dickinson & Co.), Thyl.2 
(53-2.1, Pharmingen), Thyl.1 (MRC OX-7; Serotec Ltd., Kidling- 
ton,  Oxford,  UK),  Ly-1 (CD5)  (53-7.3,  Pharmingen),  CD3e 
(145-2Cll, Pharmingen), Ly5 (B220) (CD45RA) (RA3-6B2,  Phar- 
mingen),  Ly6C  (AL-21, Pharmingen),  Pgp-1  (CD44)  (IM  7, 
Pharmingen), IgE-R (CD23) (B3B4, Pharmingen), heat stable an- 
tigen (HSA) (Jlld, Pharmingen), leukocyte cell adhesion molecule 
1 (LECAM-1) (Mel-14, Pharmingen), c~/~ TCR (H57-597, Phar- 
mingen), 2//8 TCR (GL3, Pharmingen), VB5.1 5.2 (MR 9-4, Phar- 
mingen), V/33 (KJ-25, Pharmingen), V/317a (KJ-23, Pharmingen), 
V/311 (RR3-15,  Pharmingen),  H-2K  b (AF6-885,  Pharmingen), 
H-2K  d (SF1-1.1, Pharmingen), 3Gll,  and 6C10  (25). 
Mitogenic Stimulation of  Lymphocytes In Vitro.  Lymphocytes iso- 
lated from spleen and LNs were depleted of erythrocytes by hypo- 
tonic lysis. T cells were purified by treatment with anti-J11D and 
anti-class II antibody plus complement as described by Muralidhar 
et al. (4) or enriched by nylon wool columns. Cells were cultivated 
in IMDM medium supplemented with 10% FCS (Hyclone Labora- 
tories,  Logan, UT), 2 mM t-glutamine,  1 mM sodium pyruvate, 
100  IU/ml  penicillin,  100  /~g/ml  streptomycin,  5  x  10 -5  M 
2-ME, and 10 mM Hepes in 96-well microtiter plates at 4  x  10  s 
cells per well.  Mitogen concentrations used were 5/~g/ml Con 
A, 50/zg/ml LPS, and 10/xg/ml SEB (all from Sigma Chemical 
Co., St. Louis, MO). After 48 h, the cultures were pulsed for at 
least 8 h with  [3H]thymidine (Amersham, Zurich, Switzerland) 
and harvested for counting.  Mean and SEs of triplicate cultures 
were determined. 
Neutralizing  Anti-Vasicular Stomatitis  Virus Antibody Re- 
sponses.  Mice were infected intravenously with  2  ￿  106 PFU 
vasicular stomatitis virus (VSV) in a volume of  0.2 ml. Blood samples 
were collected on days 4, 9, and 14 after infection. Anti-VSV neu- 
tralizing titers of the sera were assayed in 96-well plates as described 
by Roost et al.  (26).  IgG antibody titers were determined after 
reduction with 0.1  M  2-ME. 
Immune  Response to  Lymphocytic Choriomeningitis-WE Infec- 
tion.  Mice were infected by subcutaneous injection of 30 PFU lym- 
phocytic choriomeningitis virus (LCMV, WE strain) into footpads. 
Footpad swelling was  monitored by measurement with spring- 
loaded calliper as described by Zinkernagal et al. (27). Increase in 
footpad thickness is expressed  as a percentage of control value. 
Footpads of noninjected mice served as control. Animals were killed 
after 23 d and LCMV-WE titers in spleen,  liver, and blood were 
determined by plaque assay (27). 
Bone Marrow Reconstitution.  24  h  before the  bone  marrow 
transfer, B6-PL-Thyla mice (6-8-weeks-old), were irradiated with 
850 rad at  103 rad/min from a 127Cs animal irradiator.  Animals 
were  maintained  under  specific  pathogen-free conditions.  The 
drinking water was supplemented with 100 mg/liter neomycin and 
10 mg/liter polymixin (Sigma Chemical Co.). As radiation con- 
trols, 6-8-wk-old C57BL/6 mice were treated in parallel but not 
reconstituted with bone marrow. 3-wk-old B6/338L tg or B6 non- 
transgenic (ntg) mice of the same litter were killed. Bone marrow 
was isolated by flushing the tibias and femurs with sterile medium 
(RPMI 1640, 25 mM Hepes, 0.3% BSA). Mature T and B cells 
were depleted by treatment with polyclonal rabbit anti-mouse Ig 
(Pharmingen),  monoclonal rat anti-Thyl.2 (Pharmingen) antibodies, 
Immunodeficient HIV-1 Nef Transgenic Mice and complement-mediated lysis. 0.2 ml cell suspension (5  x  107 
cells/ml) was injected intravenously into lethally irradiated mice. 
Donor and recipients were sex matched. 
Results 
Generation of Tg Lines and Analysis of the B6/338L  Trans- 
gene Locus.  As illustrated in Fig.  1 A, the transgene con- 
struct contained a 1.5-kb  PCR fragment of the HIV-1, Bru 
genome (20), which was inserted downstream of the mouse 
TCR B chain enhancer (19) and V~8.3 promoter to target 
expression of the transgene to lymphoid cells (18). After zy- 
gote microinjection, several independent tg lines were gener- 
ated, three of which showed phenotypic changes, such as loss 
of CD4 expression  in lymphocyte populations,  thymic at- 
rophy, and reduced life span,  but to different degrees.  An 
example of a typical CD4/CD8 staining pattern of thymo- 
cytes from two different tg lines is given in Fig. 2. The most 
dramatic effects were observed  in line B6/338L. Already in 
the heterozygous state, offspring of line B6/338L were charac- 
terized by a profound immunodeficiency and a high mor- 
tality rate when kept under nonspecial pathogen free (SPF) 
conditions. Most animals died at 4-6-mo-old, whereas ntg 
littermates had normal life expectancies.  Similarly, homozy- 
gous B6/305 offspring showed a high mortality rate when 
kept under non SPF conditions, indicating impaired immune 
responses  in these animals. 
Tg line B6/338L was the only one with a single copy of 
the transgene integrated. All other lines carried multiple copies 
of the transgene.  However, the B6/338L integrated trans- 
gene was characterized by a smaller 4.5-kb band as compared 
with a 8.5-kb band in the other tg lines, that hybridized in 
Southern blots to a Nef-specific probe (Fig. 1 B). More detailed 
analysis by Southern blotting and PCR. revealed a rearrange- 
ment of the original injected construct as depicted in Fig. 
1 C. The three components of the transgene construct were 
present but in a different organization. This organization, 
however,  resembles  the natural configuration of the mouse 
TCR 3 chain locus where the enhancer is located downstream 
of the TCR 3  chain gene. A likely explanation for the rear- 
rangement is a partial deletion of the 5' and 3' ends of two 
tandem copies  during the integration process. 
To determine whether the nefORF and the V38.3 pro- 
moter of the B6/338L transgene were still intact, fragments 
were cloned by PCR amplification from either genomic DNA 
or from thymic cDNA templates and sequenced.  No muta- 
tions to the original nefgene and V38.3 promoter sequence 
used for zygote injections or to transgenes cloned from other 
tg lines were found (data not shown). 
To exclude the presence  of a MAIDS-inducing defective 
retrovirns in the tg lines, Southern blots were screened with 
a BMS-defective, retrovirus-specific  probe (100-bp SalI-XbaI 
fragment of plasmid pGEN-3 BM5d/Dp12a; 28). No BMSd- 
specific hybridization pattern as described by Chattopadhyay 
Figure  1.  The TCR-NEF transgene construct and the B6/388L integration  locus. (A) The mouse  TCR. O chain enhancer-promoter  element  was 
constructed  by fusion  of a 5.5-kb BamHI/Kpnl  fragment  containing  the mTCR/~  chain  core enhancer  elements  (19) to a 1.8-kb BamHl/KpnI  fragment 
containing the mV~8.3 TCR ~ chain promoter. This control element was hooked  up to a PCR fragment comprising nt 7956-9484 of the HIV-1 
Bru genome (20) containing  the complete nefORE (B) Southern blot analysis  of genomic DNA digested  with EcoR.I/Asp718 from: (lane 1) ntg; 
(lane 2) B6/338L; and (lane  3) B6/305 littermates  with a nef-specific  probe. No crosshybridization  of the nef-specific  probe with endogenous  retroviral 
sequences  in tg or ntg littermates  was observed. (C) The B6/338L  locus. Schematic  illustration  of  the B6/338L  transgene  locus  as deduced  from  Southern 
blot analysis  with different  restriction  enzymes  hybridized  to nefor  TCR B chain  enhancer-specific  probes (19), and PCR analysis  with different  transgene- 
specific oligonucleotides. 
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Figure  2.  CD4/CD8 staining pattern of tg and ntg thymocytes. Cells 
were  labeled  with  PE-conjugated  anti-mouse  CD4  and  biotinylated 
anti-mouse CD8, and subsequently with Streptavidin-Tandem by standard 
procedures  and analyzed on a FACScan  |  instrument  (Becton Dickinson 
& Co.). 
et al.  (28)  was detected (data not  shown).  The nef-specific 
hybridizing probe used for identification of tg offspring did 
not recognize any endogenous MuLV sequences (see Fig. 1 B). 
Transgene  Expression.  Transgene expression was monitored 
by  a  RNA-PCR  method  using  primer  pairs  specific  for 
transgene-derived messages (see Materials and Methods). An 
example of an ethidium bromide-stained agarose gel elec- 
trophoresis of nef-specific amplification products derived from 
total thymic RNA  templates of B6/338L  mice is given in 
Fig. 3 A. PCR products were cloned and sequenced to confirm 
the specifcity of the amplification. A he, specific 1.2-kb frag- 
ment was visible in tg samples only. TCR ~ chain messages 
could be detected in most lymphoid samples,  using mTCR 
CB2  gene-specific primers (Fig.  3 B). 
RNA samples of different organs from B6/338L mice of 
various stages were analyzed. An overview of transgene ex- 
pression in lymphoid organs is given in Table 1. nefmRNA 
could be detected in the thymuses of B6/338L  mice at all 
time points analyzed, even at the earliest embryonic stages, 
indicating that the first intrathymic precursors already seemed 
to express the transgene. At day 91, no analysis could be made 
because in these mice a thymus was not present anymore. 
In LN samples only, a weak signal was obtained at day 29, 
whereas all other samples were negative. However, in spleen, 
strong positive signals were obtained at days 29 and 45. Spleen 
samples of older and younger animal were negative. In bone 
marrow and liver samples, no positive signal was ever ob- 
tained. All RNA samples of lymphoid organs from day 15 
in ontogeny onwards were positive for TCR B chain mes- 
sage (data not shown).  Other organs tested, such as lung, 
heart, brain,  kidney, and skin,  as well as all samples  from 
ntg littermates, were negative for nef-specific transcripts (data 
not shown). Preliminary experiments showed that similar dis- 
tribution of Nef  expression--strong expression in the thymus, 
lower expression in the peripheral lymphoid organs -was de- 
tected in B6/305  mice. 
Thymocyte Populations.  Macroscopic analysis of B6/338L 
offspring revealed signs of thymic atrophy in animals younger 
than 8 wk old. In animals older than 8 wk old, the thymus 
often completely disappeared with time. In addition, older 
mice developed lymphadenopathy and splenomegaly. 
Dramatic changes in thymocyte populations of B6/338L 
mice were demonstrated by subjecting thymocytes to FACS  | 
analysis  (Becton Dickinson  &  Co.).  The  total number of 
thymocytes isolated from 6-8-wk-old mice was reduced 5-10- 
fold  compared  with  ntg  littermates.  Furthermore,  the 
CD4 +  CD8 + cells, which normally constitute the majority 
of the thymocytes, were almost completely  lacking in B6/338L 
mice  (Fig.  2).  In  contrast,  the  largest  population  were 
CD8 § CD4-  thymocytes, which represented only a minor 
fraction in ntg littermates. However, only a minority of these 
CD8+CD4 -  cells  expressed high  levels of CD3  and low 
levels of HSA, two characteristic markers of mature CD8 + 
cells (data not shown). Most of these cells showed cell surface 
marker expression found on CD4+CD8 + cells  in  normal 
mice  except  for  their  lack  of  CD4  expression.  The 
CD4-CD8-  population  and cells expressing intermediate 
levels  of CD8  were  found  to  be  increased  as  well.  No 
CD4+CD8 -  thymocytes were detected (Fig.  2).  In other 
TCR-NEF  tg lines,  B6/305  (Fig.  2) and B6/553  (data not 
shown), a  similar depletion of CD4 + cells in  the thymus 
was observed, but  to  a lesser  degree. Compared with ntg 
littermates, total CD4 § thymocyte numbers were decreased 
200-300-,  15-20-, and 8-10-fold in heterozygous B6/338L, 
B6/305,  and B6/553  mice, respectively. 
Thymocyte Populations  during Ontogeny.  Single cell suspen- 
sions of thymus from prenatal stages of B6/338L mice were 
analyzed by FACS  |  to determine at what time point of de- 
velopment  the  depletion  of the  CD4 § CD8 §  and  CD4 § 
CDS-  thymocyte population occurred. As shown in Fig. 4, 
at day 15 of gestation, first CD4-CD8 t~  CD4t~ 
and  CD41~163176  thymocytes  were  detected  in  ntg 
thymus, whereas the overall majority of tg thymocytes was 
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Figure  3.  PCR amplification of transgene and 
mTCR 3 chain messages. Agarose gel electropho- 
resis of (A) 2  nd  PCR products  with transgene- 
specific primers  and  (B) 2  nJ PCR products  with 
mTCR ~ chain C2-specific primers.  Sizes of con- 
trol DNA fragments are shown in kilobases. Lanes 
(M) DNA size marker (1-kb ladder, Gibco BRL); 
(ntg) total thymus RNA from ntg day 16 embryos; 
(tg) total thymus  RNA from tg day 16 embryos; 
(control)  no RNA; (+) addition  of reverse tran- 
scriptase (RT) to cDNA mix; (-) no addition of 
RT to cDNA mix. For details of the RNA-PCR 
procedure,  refer to Materials  and  Methods. Table  1.  Overview of Transgene Expression in B6/338L  Mice 
Prenatal  Postnatal 
Tissue  El3  El4  El5  El6  El7  El8  dl  d3  d6  dl0  d14  d21  d29  d45  d91 
Thymus  +  +  +  +  +  +  +  +  +  +  +  +  +  +  ND 
Liver  .......  ND  ND  ND  ND  ND  -  -  - 
Spleen  ND  ND  ..........  +  +  - 
LN  ND  ND  ND  ND  ND  ND  ND  .....  _+  -  - 
Bone marrow  ND  ND  ND  ND  ND  ND  ND  ND  ND  ND  ..... 
1-5/~g of total RNA from different tissues was used as template for R.NA-PCR amplification with  transgene-specific primers. ( + ) Expression; 
(-) no expression; (_+) very weak expression. 
CD4-CD8-.  A  CD4+CD8 +  thymocyte population  was 
present in ntg thymus on day 16 of gestation, when the deple- 
tion of this population was already prominent in tg thymus. 
Only very low CD4 expression was observed on tg thymo- 
cytes. 1 or 2 d before birth, at day 18 of gestation, the overall 
majority  of ntg  thymocytes had  the  CD4+CD8 +  pheno- 
type,  whereas  in  tg thymus,  larger  populations  of CD4- 
CD8 §  and  CD4-CD8-  cells were  observed. 
These results  suggest  that  transgene  expression leads  to 
a depletion of CD4-positive thymocytes already at the earliest 
stages in embryogenesis.  The mechanism that leads to this 
effect,  however,  is  still  unclear. 
Thymic Populations in C57BL/6 Mice Reconstituted with tg 
Bone Marrow.  Reconstitution experiments were performed 
to investigate the role of B6/388L bone marrow-derived he- 
matopoietic cells versus those of thymus and lymphoid organs 
in  the  generation  of the  severe  immunodeficiency  of the 
B6/388L tg mouse line.  B6-PL-Thyl  a mice expressing the 
Thyl.1 allele on T  cells were chosen as recipients to distin- 
guish T cells derived from the donor bone marrow of B6/338L 
or B6/ntg mice expressing the Thyl.2 allele  from those de- 
rived from the endogenous bone marrow.  6-8-wk-old B6- 
PL-Thyl a mice  were  lethally  irradiated  and  reconstituted 
with bone marrow of 3-wk-old heterozygous B6/338L tg 
mice or B6/ntg control mice of the same litter,  as described 
in Materials  and Methods. 
Reconstituted mice survived irradiation and some of them 
were killed 8 and 12 wk after transfer for thymocyte analysis. 
Mice reconstituted with B6/ntg bone marrow showed normal 
ratios  of  CD4-CDS-,  CD4+CD8 +,  CD4-CD8 +,  and 
CD4+CD8 -  thymocytes  (Fig.  5  A).  In  contrast,  almost 
complete depletion  of CD4+CD8 + and CD4+CD8 -  cells 
was seen in mice reconstituted with B6/338L bone marrow. 
The increase of the CD4- CD8-  and CD4- CD8 + popula- 
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Figure 4.  CD4/CD8  staining 
pattern of ntg and tg thymocytes 
from fetal thymus at day 14-16 and 
day 18 of gestation. Timed matings 
with B6/338L males and C57BL/6 
females were set  up.  The day at 
which a vaginal plug was observed 
was taken as day 0. Pregnant females 
were killed at day 13-18 of gesta- 
tion. The fetal thymuses  of  6-10 em- 
bryos per time point were removed. 
Genomic DNA samples were pre- 
pared from tail biopsies, and by PCR 
analysis tg and ntg embryos were 
identified. Single cell suspensions of 
thymocytes were stained with PE- 
conjugated anti-mouse  CD4 and bi- 
otinylated anti-mouse CD8, subse- 
quently with Streptavidin-Tandem, 
and analyzed by flow cytometry. 
(~bp) The time point of gestation. 
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Figure  5.  Thymocyte populations  of reconstituted  B6/Thyl  a mice. 
Cells from B6/Thyla mice were labeled (A) with PE-conjugated anti-mouse 
CD4 and biotinylated anti-mouse CDS, and subsequently with Streptavidin- 
Tandem;  or  (B)  with  FITC-conjugated  anti-mouse  Thyl.1  and  PE- 
conjugated  anti-mouse Thyl.2 antibodies 8 wk after reconstitution with 
B6/338L tg or ntg bone marrow. 
tion, as well as their CD3e and HSA expression pattern is 
analogous to that found in thymuses of B6/338L mice (data 
not shown). Total  thymocyte numbers of these mice were 
reduced three to sixfold when compared with the control 
mice. In the thymuses of both types of reconstituted mice, 
only very few cells could be detected as expressing Thyl.1, 
and most of them were Thyl.2 positive (Fig.  5 B). Thyl.2 
staining also revealed the presence of a proportion of Thyl.2- 
negative/Thyl.l-negative cells  in mice reconstituted with 
B6/338L bone marrow, which was not found in mice recon- 
stituted with B6/ntg bone marrow. 
Taken  together, these experiments demonstrate that  the 
phenotypic changes in the thymocyte population of B6/338L 
tg mice are inherent to bone marrow-derived cells and are 
not due to a defect of thymic epithelium as found, for ex- 
ample, in nude mice. 
Pe@heral Lymphocyte Populations.  To address the question 
of whether these changes in thymus (Fig. 6, A and B) would 
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influence the distribution of the peripheral lymphocyte popu- 
lation, lymphocytes were isolated from LNs and spleens and 
analyzed by FACS  |  As mentioned earlier, B6/338L mice de- 
veloped lymphadenopathy and splenomegaly starting at about 
6-8  wk after birth.  Expansion of lymphocytes continued 
throughout their life span,  as the total number of cells in 
LNs and spleen increased up to 10-fold over controls. The 
percentage of T cells in the periphery was reduced 5-10-fold, 
as demonstrated by Thyl or CD4/CD8 staining (Fig.  6, C 
and D), mainly because of a large increase of the B cell popu- 
lation. The actual number of T  cells in older mice was re- 
duced only two- to three-fold because of the enlargement 
of lymphocyte populations.  The ratio of CD4 § to CD8 + 
cells, about 2:1 in normal mice, was as low as 0.5:1. B6/338L 
peripheral T cells also showed major phenotypic alterations 
compared with ntg controls. Their expression of CD8 and 
CD3 was reduced. A substantial fraction of the CD8 + cells 
is most probably NK cells, as they were CD3-  (Fig.  6 G) 
and expressed the murine NK cell marker NKI.1 (data not 
shown). 
In the mouse system, naive T  cells can be distinguished 
from memory or  antigen-triggered T  cells by differential 
expression of the cell surface markers Pgp-1 (CD44) and Mel-14 
(LECAM-1) (29).  Naive T  cells express low levels of Pgp-1 
and high levels of Mel-14; memory or activated T cells ex- 
press high levels of Pgp-1 and low levels of Mel-14. In con- 
trol mice, only a minor population expressed high levels of 
Pgp-1 and low levels of Mel-14 (Fig.  6, H  and/),  whereas 
in B6/338L mice, the majority of peripheral T cells had this 
phenotype (Fig. 6, H and ,I). Recently Hayakawa and Hardy 
(25) described four subsets  of peripheral CD4 + T  cells ac- 
cording to their differential expression of the 6C10 and 3Gll 
antigens, which show differential growth potential and dis- 
criminate  virgin  and  memory or  activated  T  cells.  The 
3Gl1+6C10-  subset was the predominant population in ntg 
mice. In B6/338L mice, a clear shift towards the double nega- 
tive subsets was observed (Fig. 6, E and F). Taken together, 
these data show that the changes in tg thymocyte popula- 
tions lead to a drastic depletion of peripheral T ceils. In addi- 
tion, they indicate that as in the MAIDS mice (1, 4) the pe- 
ripheral T  cells in B6/338L  mice show cell surface marker 
expression  characteristic of memory or  activated T  cells, 
whereas virgin T  cells seem to be absent. 
In Vitro Stimulation of  Peripheral  Lymphocytes.  To study the 
functional capacity of B6/338L lymphocytes in vitro, lym- 
phocytes were prepared from LNs and spleen and stimulated 
with different mitogens. For cell proliferation assays, either 
total cells (Fig.  7, A  and B) were used or T  cells were en- 
riched (Fig. 7 C) to compensate differential proliferation due 
to the different frequencies ofT cells in B6/338L mice. Lym- 
phocytes isolated  from  spleen  or LN  showed only weak 
proliferation upon stimulation with Con A or SEB (Fig.  7, 
A and B) even when IL-2 was included in the culture medium. 
The LPS response was drastically reduced when using spleen 
cells (Fig. 7 A), but, only a two to three-fold reduction was 
observed with LN cells (Fig.  7 B).  Cultures with adjusted 
numbers of T  cells showed a six to eight-fold reduction in 
response to Con A  stimulation  (Fig.  7 C). 
Transgenic Mice Figure 6.  Cell  surface marker analysis of cells 
from different  lymphoid  tissues of  B6/338L mice. 
Thymocytes  of 6-wk-old (A) nontransgenic  (ntg) 
or (B) B6/338L transgenic (tg) littermates were 
stained with PE-conjugated  anti-mouse  CD4 and 
biotinylated anti-mouse CD8, and subsequently 
with Streptavidin-Tandem.  CD4/CD8 staining of 
LN cells of (C) ntg or (D) tg offspring. Spleen 
cells were stained with PE-conjugated  anti-mouse 
CD4  and biotinylated mAb  3Gll  and  FITC- 
conjugated 6C10. Only CD4 + cells  were acquired 
(inset). 3Gll/6C10 profile  is shown for (E) ntg or 
(F)  tg  mice. LN cells were stained with  PE- 
conjugated anti-mouse CD4, FITC-conjugated 
anti-mouse CD8, and counterstained  with anti- 
bodies to (G) biotinylated  anti-mouse  CD3-E, (/-/) 
biotinylated  anti-mouse Pgp-1 (CD44), or (/) bi- 
otinylated  anti-mouse Mel-14  (LECAM-1). 
CD4-CD8- cells were omitted during acquisi- 
tion. (Shaded  curves) The staining of  B6/338L  cells; 
(unfilled curves) staining of ntg controls. 
In Vivo Immune Responses.  The in vivo immune responses 
of B6/338L  mice were  studied by infection with  various 
viruses.  To test whether B6/338L mice were able to generate 
a normal antiviral humoral response, 8-wk-old mice were in- 
fected with VSV. The efficiency of the response was assessed 
by determination of the serum titer of virus neutralizing an- 
tibodies at different time points. In B6/338L mice, anti-VSV 
IgM responses measured on day 4 after infection were normal, 
however, the T  cell-dependent neutralizing IgG antibodies, 
determined on days 9 and 14, were reduced when compared 
with controls (Table 2).  These results illustrate the impair- 
ment of B6/338L T  h cell responses involved in switching 
anti-VSV antibody responses from IgM to  IgG. 
CD8 §  T  cell responsiveness was tested in mice infected 
with LCMV (27). Subcutaneous inoculation of LCMV (WE 
strain) into footpads of mice normally induces a virus-specific 
swelling reaction. The initial major swelling which is max- 
imal around day 8, is mediated by CD8 + T  cells, followed 
by a  late  minor  swelling  phase  around  day  12,  which  is 
CD4 § T  cell dependent (27). This typical reaction was in- 
deed observed in the control mice. However, B6/338L mice 
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infected with LCMV-WE showed no measurable swelling 
reaction in the footpads (Table 3). This unresponsiveness again 
illustrates the functional defect of T  cells in B6/338L mice. 
CD8 + T  cells  are  also  crucial for the clearance of LCMV 
after acute infection (30). As reported previously, in normal 
mice LCMV virus was  detected in  the spleen on days 4-6 
after infection, but no virus could be demonstrated after day 
23 (30). In contrast, B6/338L mice still contained high virus 
titers on day 23 after subcutaneous infection (Table 3). These 
results suggest that the CD8 + T cells of B6/338L mice were 
not able to induce a protective virus-specific CTL response. 
Discussion 
The data presented here suggest an association of a HIV-1 
NEF/3' LTR transgene with a severe immunodeficiency, as 
manifested by the lack of responsiveness of tg lymphocytes 
to mitogenic stimuli, defective immune response to various 
viral infections and enhanced susceptibility to infections. The 
similarities to MAIDS and to human AIDS are striking and 
a further study of this tg mouse line might lead to a better A 
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Figure  7.  Proliferative responses of B6/338L and ntg lymphocytes  to 
mitogenic stimulation.  Lymphocytes  isolated from spleen (A) and LNs 
(B) were depleted of erythrocytes by hypotonic lysis. (C) T cells from LNs 
were enriched by nylon wool columns.  T cell numbers were adjusted ac- 
cording to anti-Thyl.2  FACS  |  staining.  Cells were cultivated  in IMDM 
supplemented with 10% FCS (Hyclone Laboratories), 2 mM t-glutamine, 
1 mM sodium pyruvate,  100 IU/ml penicillin,  100 #g/ml streptomycin, 
5  ￿  10 -5 M  2-ME,  and  10 mM Hepes  in 96-well microtiter plates at 
1-4  x  105 cells per well. Mitogen concentrations used were 5/zg/ml Con 
A, 50 #g/ml LPS, and  10/xg/ml SEB. After 48-72 h the cultures  were 
pulsed for at least 8 h with [3H]thymidine  and harvested for counting. 
Mean  and SEs of triplicate  cultures  are shown. 
understanding  of the pathogenesis of AIDS. Accidental in- 
fection of our mice with a MAIDS-inducing retrovirus mix- 
ture could be excluded by Southern  analysis  using a BM5 
defective probe as described by Chattopadhyay  et  al.  (28). 
Whether T  cell-specific expression of the HIV-1 nef gene 
product leads directly to the deficiency in thymocyte devel- 
opment as observed in the tg B6/338L mice remains to be 
proven. Low levels of neftranscripts  could be detected by RNA- 
PCR in the thymus of B6/338L mice, as well as in B6/305 
mice (data not shown). So far we have not been able to de- 
tect the presence of Nef protein in any of the transgenic lines. 
Work is in progress to improve the sensitivity of the methods 
used. Nevertheless, the downregulation of CD4 observed in 
thymocytes of different independent tg lines would fit in with 
reports demonstrating  a downregulation  of CD4 from the 
cell surface in response to Nef expression in transfected human 
(15) and mouse T  cell lines  (31). 
Differences in the genetic backgrounds of the tg lines due 
to the (C57BL/6  x  DBA/2)F2 zygotes used for injection 
could be responsible for the differential effects seen. In the 
case of MAIDS, for example, it is known that only certain 
strains  of mice develop the immunodeficiency, according to 
their MHC haplotypes and other genetic determinants  (1). 
Backcrossing of the B6/338L locus into different mouse strains 
should clarify this point.  In addition,  the unique organiza- 
tion of the transgene or the integration site can lead to differen- 
tial expression during embryogenesis and/or differentiation 
of T  cells,  and thus may account for the strong effects ob- 
served in B6/338L mice versus the less obvious changes in 
other tg lines.  It has been shown for several tg lines that the 
site of integration  can influence the timing and magnitude 
of transgene expression (32).  Another possible explanation 
for the B6/338L phenotype could be an insertional  muta- 
tion.  Although  this cannot be excluded formally,  it  seems 
rather unlikely because of the following reasons:  first,  inser- 
tional mutations in tg animals tend to be recessive (32) (the 
B6/338L phenotype is dominant);  and second, two other 
independent HIV-1 NEF/Y LTR tg mouse lines show similar 
effects with respect to CD4 expression,  atrophy of the thymus 
and reduced life  spans. 
Finally,  reconstitution  experiments  indicate  that  the 
B6/338L phenotype can be established in normal C57BL/6 
mice by bone marrow transfer.  This finding would suggest 
that  the immunodeficiency phenotype in B6/338L mice is 
caused by a bone marrow-derived defect that leads to an im- 
paired  recruitment  of precursor  T  cells  in  the  thymus,  a 
phenomenon that is believed to also occur in AIDS patients. 
During the course of the preparation of this manuscript, 
Skowronski et al.  (33) reported  the generation  of tg mice 
carrying the nefgene under control of the CD38 promoter-en- 
hancer.  Similar to our TCR-NEF mice, these mice show a 
depletion of CD4-positive thymocytes and peripheral T cells, 
but to a lesser degree than in our B6/338L mice. In addition, 
the authors report a hyperreactivity of CD3-NEF1 tg thymo- 
cytes to TCR stimulation,  however, no data on mitogenic 
stimulatory capacity of tg peripheral lymphocytes or on the 
capacity of tg mice to generate immune responses to specific 
pathogens were presented.  The authors suggest that this hyper- 
responsiveness of the CD3-NEF1  tg thymocytes may lead 
to the direct  elimination  rather  than  the positive selection 
of these cells, which is manifested in peripheral T cell deple- 
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Neutralizing  antibody titers  (logz  x  40) 
Day 4  Day 9  Day 14 
Mouse  IgM/IgG  IgG  IgM/IgG  IgG  IgM/IgG  IgG 
B6/338L I  9  <1  7  3  2  <1 
B6/338L II  7  (1  .... 
B6/338L III  8  (1  5  3  2  1 
B6/ntg I  8  <1  11  7  11  9 
B6/ntg II  7  <1  11  7  9  9 
B6/ntg III  8  <1  11  8  9  9 
Neutralizing anti-VSV antibody responses of B6/338L or B6/ntg littermates. Mice were infected intravenously with 2  x  106 PFU in 0.2 ml. Blood 
samples were collected on days 4, 9, and 14 after infection. Anti-VSV neutralizing titers of the sera were assayed in 96-well plates as described else- 
where (26). IgG antibody titers were determined after reduction with 0.1 M 2-ME. One mouse died of VSV (*). This correlates with increased 
susceptibility to VSV in the absence of an IgG response (34). 
Table  3.  In  Vivo Analysis  of Immune Responses to Infection with  Different  Viruses II 
Percent  swelling vs.  control on day  LCMV-WE clearance  by day 23 
PFU/  PFU/  PFU/ 
Mouse  6  8  13  15  spleen  liver  ml blood 
B6/338L I  <5%  <5%  <5%  <5%  1.8  x  105  3.0  x  107  2.5  x  10  f 
B6/338L II  <5%  <5%  <5%  <5%  1.5  x  106  2.4  x  107  3.8  x  104 
B6/ntg I  <5%  100%  10%  <10%  <i02  <10  ~  <10  z 
B6/ntg II  <5%  90%  15%  <10%  <102  <102  <102 
Immune response to LCMV-WE infection. Mice were infected with 30 PFU into footpads. Footpad swelling was monitored by measurement with 
spring-loaded calliper (27). Increase  in footpad thickness is expressed as a percentage of control value. Footpads of noninjected mice served as controls. 
Animals were killed after 23 d and LCMV-WE titers in spleen, liver, and blood were determined by plaque assay (27). 
tion. This is in line with our observations of an unresponsive 
state of the residual peripheral T  cells and impaired immune 
responses  to  specific  pathogens  in  B6/338L  mice.  These 
unresponsive T  cells,  whose number is  reduced drastically 
compared with the T  cell population of normal mice, may 
represent  a small population of tg thymocyte escaping the 
deleterious effect of Nef expression and/or CD4 downregu- 
lation by a  so far undetermined  mechanism.  Interestingly, 
in B6/338L as well as CD3-NEF1 tg mice, Nef expression 
seems to be strongly reduced in peripheral  lymphocytes as 
compared with thymocytes, suggesting the reduction or elimi- 
nation of transgene expression to be the mechanism to es- 
cape elimination  in the  thymus. 
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